HHS Delays Trump Insulin, Epinephrine Rule Until July for Review

The HHS on Friday delayed until July 20 a Trump administration drug rule that requires community health centers to pass on all their insulin and epinephrine discount savings to patients.

Centers that don’t pass on the savings wouldn’t qualify for federal grants. The Department of Health and Human Services under President Joe Biden initially delayed the effective date of the rule (RIN 0906-AB25) until March 22. It was finalized in late December. The HHS said it’s extending the hold for a few more months to give agency officials more opportunity to review the rule and ensure it would not impede ...